Bayer Sverige in the news

Bayer is expanding its Dekalb maize offerings in Sweden due to increased grower interest in silage maize.

Bayer is expanding its Dekalb maize offerings in Sweden due to increasing farmer interest in silage maize.

Sweden is planning to introduce a new category of over-the-counter medicines that require professional pharmacist advice to ease healthcare pressure.

Bayer launched MeroPower/FieldPower, an additive improving herbicide efficacy against tough grass weeds like ryegrass and silky bent, vital for reducing seed banks in affected fields.

Serenade Soil Activ is a biological fungicide improving potato peel quality and nutrient content while protecting against fungal diseases, proven effective in trials and widespread use.

Bayer loses its Swedish patent for the blood thinner Xarelto, allowing generic competition.

Svea hovrätt's Patent and Market Court of Appeal invalidated Bayer's European patent for the cancer drug Nexavar in Sweden, ending a multi-year legal dispute against generic company Mylan.

Bayer Sverige emphasizes the importance of clinical trials for developing new medicines and improving patient access, while addressing the decline in trial applications in Sweden and advocating for initiatives like Swetrial and better health data utilization.

Bayer introduces Hingios, a new growth regulator for winter rapeseed in Sweden, designed to enhance winter hardiness and reduce lodging.

New high-yielding and frost-resistant rapeseed varieties DK Exagris and DK Excentric are being launched for Swedish farmers.

Bayer is launching MagicTrap in Sweden, a solar-powered digital insect trap that uses automated image analysis to help farmers monitor pest levels remotely via an app.

Bayer Crop Science in Sweden launches Atlantisvädret, a free weather-based tool for farmers to optimize the timing of grass weed herbicide applications.

Jesper Edlund is the new CEO of Bayer Sweden, succeeding Tomer Feffer.

Per Edlund is the new CEO of Bayer AB, a global life science company.

Fredrik Edlund is the new CEO of Bayer's Swedish operations, replacing Tomer Feffer.

Bayer warns that the EU Commission's proposed pharmaceutical legislation risks hindering innovation, weakening intellectual property rights, and reducing access to precision medicine.

Bayer's over-the-counter medicines received the 'Välvald' sustainability label for the third year, meeting stricter criteria for responsible and transparent manufacturing.

Bayer Sverige, a life science solutions provider, operates in pharmaceuticals, consumer health, and agriculture, contributing to global health and sustainability goals.

Bayer is restructuring its Swedish operations and has appointed Karin Eidolf and Martin Stagmo to new leadership positions.

Karin Eidolf is the new Sweden Country Manager as the company adopts a more customer-centric and agile organizational model for its pharmaceutical business.